Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers.

OBJECTIVE Our purpose was to evaluate the usefulness of prenatal ultrasonography among women with a positive screen for fetal Down syndrome on the basis of three biochemical markers--maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. STUDY DESIGN A total of 395 women underwent prenatal ultrasonography at a single institution after being identified as screen positive (midtrimester risk > or = 1:195) on the basis of triple-marker screening between 15 and 18 weeks. Ultrasonographic findings were compared with the biochemical markers and the eventual fetal outcome for these patients. Ultrasonographic abnormalities that were evaluated included structural defects, nuchal thickening or cystic hygroma, echogenic bowel, cerebral ventricular dilatation, pyelectasis, and shortened femur. RESULTS Among 395 patients, 374 (94.7%) had normal karyotype by genetic amniocentesis (n = 232) or postnatal follow-up (n = 142), 18 (4.5%) proved to have Down syndrome, and three had other karyotypic abnormalities. One or more ultrasonographic abnormalities were found in nine of 18 (50%) with Down syndrome compared to 27 of 377 (7.2%) other fetuses (p < 0.001). Fetuses with abnormal ultrasonography results included three with other chromosome abnormalities and five with nonchromosomal anomalies. An abnormal ultrasonography result increased the risk of Down syndrome by 5.6-fold (25% from 4.5%) and a negative result reduced the risk by 45% (2.5% from 4.5%). The value of ultrasonography is further enhanced when all chromosome abnormalities and nonchromosomal anomalies are considered. CONCLUSION Abnormal ultrasonographic findings increase the risk for Down syndrome, whereas normal findings are less predictive of normalcy. After correction for inaccurate menstrual dates, genetic amniocentesis should be offered in spite of a normal ultrasonography result among women with positive triple screen.

[1]  K. Nicolaides,et al.  Fetal lateral cerebral ventriculomegaly: associated malformations and chromosomal defects. , 1990, Fetal diagnosis and therapy.

[2]  D. Guzick,et al.  The Current Role of Sonography in the Detection of Down Syndrome , 1989, Obstetrics and gynecology.

[3]  Walter E. Johnson,et al.  An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities , 1984 .

[4]  M. Sharf,et al.  The Association Between Unexplained Second- Trimester Maternal Serum hCG Elevation and Pregnancy Complications , 1992, Obstetrics and gynecology.

[5]  Prenatal screening for Down's syndrome with use of maternal serum markers. , 1993, The New England journal of medicine.

[6]  I. Forouzan.  Fetal abdominal echogenic mass: An early sign of intrauterine cytomegalovirus infection , 1992, Obstetrics and gynecology.

[7]  J. Canick,et al.  Maternal serum screening for aneuploid pregnancy by alphafetoprotein, hCG, and unconjugated estriol , 1990, Obstetrics and gynecology.

[8]  Bellet Re,et al.  Letter: ICRF 159. , 1974 .

[9]  D. Nyberg,et al.  Prenatal sonographic findings of Down syndrome: Review of 94 cases , 1990, Obstetrics and gynecology.

[10]  D. Nyberg,et al.  Echogenic fetal bowel during the second trimester: clinical importance. , 1993, Radiology.

[11]  N. Wald,et al.  MATERNAL SERUM ALPHA-FETOPROTEIN MEASUREMENT: A SCREENING TEST FOR DOWN SYNDROME , 1984, The Lancet.

[12]  J. Canick,et al.  Maternal serum screening for Down's syndrome in early pregnancy. , 1988, BMJ.

[13]  J. Canick,et al.  Prenatal screening for Down's syndrome with use of maternal serum markers. , 1992, The New England journal of medicine.

[14]  M. Gravett,et al.  Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome. , 1992, American journal of medical genetics.

[15]  K. Nicolaides,et al.  Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency , 1995, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[16]  B. Pletcher,et al.  INTRAUTERINE CYTOMEGALOVIRUS INFECTION PRESENTING AS FETAL MECONIUM PERITONITIS , 1991, Obstetrics and gynecology.

[17]  J. Corteville,et al.  Fetal Pyelectasis and Down Syndrome: Is Genetic Amniocentesis Warranted? , 1992, Obstetrics and gynecology.

[18]  D. Nyberg,et al.  Prenatal sonographic findings of trisomy 18: review of 47 cases , 1993, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[19]  K. B. Porter,et al.  Fetal abdominal hyperechoic mass: diagnosis and management. , 1992, Fetal Diagnosis and Therapy.

[20]  D. Neuberg,et al.  Sonographic Scoring Index for Prenatal Detection of Chromosomal Abnormalities , 1992, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[21]  J. Estroff,et al.  Fetal Pyelectasis: A Possible Association With Down Syndrome , 1990, Obstetrics and gynecology.

[22]  J. Canick,et al.  Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome , 1988, British journal of obstetrics and gynaecology.

[23]  N. Wald,et al.  Ultrasound fetal femur length measurement in the screening for Down's syndrome , 1989, British journal of obstetrics and gynaecology.

[24]  B. Benacerraf,et al.  Sonographic identification of second-trimester fetuses with Down's syndrome. , 1987 .

[25]  D. Luthy,et al.  A Prospective Evaluation of a Second-Trimester Screening Test for Fetal Down Syndrome Using Maternal Serum Alpha-Fetoprotein, hCG, and Unconjugated Estriol , 1993, Obstetrics and gynecology.

[26]  D. Nyberg,et al.  Mild idiopathic lateral cerebral ventricular dilatation in utero: sonographic evaluation. , 1988, Radiology.

[27]  J. R. Beekhuis,et al.  Increased maternal serum alpha‐fetoprotein and human chorionic gonadotropin in compromised pregnancies other than for neural tube defects or Down syndrome , 1992, Prenatal diagnosis.

[28]  D. Luthy,et al.  Presented by invitation at the Fifty-ninth Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, Ojai, California, October 11-18, 1992. , 1993 .

[29]  B. Bromley,et al.  Mild fetal lateral cerebral ventriculomegaly: clinical course and outcome. , 1991, American journal of obstetrics and gynecology.

[30]  M. Bogart,et al.  Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities , 1987, Prenatal diagnosis.

[31]  D. Nyberg,et al.  Femur length shortening in the detection of Down syndrome: is prenatal screening feasible? , 1990, American journal of obstetrics and gynecology.

[32]  G. Leopold,et al.  Second-trimester echogenic bowel and chromosomal abnormalities. , 1992, American journal of obstetrics and gynecology.

[33]  J. Simpson,et al.  Maternal Serum Screening for Fetal Down Syndrome in Women Less Than 35 Years of Age Using Alpha-Fetoprotein, hCG, and Unconjugated Estriol: A Prospective 2-Year Study , 1992, Obstetrics and gynecology.

[34]  D. Nyberg,et al.  Humerus and femur length shortening in the detection of Down's syndrome. , 1993, American journal of obstetrics and gynecology.

[35]  D. Neuberg,et al.  Humeral shortening in second-trimester fetuses with Down syndrome. , 1991 .

[36]  K. Nicolaides,et al.  Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. , 1992, BMJ.

[37]  J. Rodis,et al.  Efficacy of the biparietal diameter/femur length ratio to detect Down syndrome in patients with an abnormal biochemical screen. , 1994, Fetal diagnosis and therapy.

[38]  D. Hickok,et al.  Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension. , 1993, American journal of obstetrics and gynecology.

[39]  D. Gray,et al.  Sonographically Measured Nuchal Skinfold Thickness As a Screening Tool for Down Syndrome: Results of a Prospective Clinical Trial , 1991, Obstetrics and gynecology.

[40]  K. Nicolaides,et al.  Ultrasonographically detectable markers of fetal chromosomal defects , 1993, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.